Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer.
Ino K, Yoshida N, Kajiyama H, Shibata K, Yamamoto E, Kidokoro K, Takahashi N, Terauchi M, Nawa A, Nomura S, Nagasaka T, Takikawa O, Kikkawa F.
Ino K, et al.
Br J Cancer. 2006 Dec 4;95(11):1555-61. doi: 10.1038/sj.bjc.6603477. Epub 2006 Nov 21.
Br J Cancer. 2006.
PMID: 17117179
Free PMC article.